Achaogen, Inc. Company Profile

07:59 EDT 20th August 2017 | BioPortfolio

Achaogen is a clinical-stage biopharmaceutical company focused on the discovery and development of antibiotics for the treatment of serious infections caused by multi-drug resistant, Gram-negative bacteria. The company’s pipeline includes ACHN-490, an aminoglycoside currently being evaluated in a Phase 2 clinical study for the treatment of complicated urinary tract infection (cUTI) and acute pyelonephritis, and late-stage preclinical programs with demonstrated in vivo efficacy against Gram-negative pathogens of concern including P. aeruginosa and A. baumannii. Resistance to available antibacterial therapies continues to rise at an alarming rate and Achaogen is applying its anticipatory science to meet this evolving need, developing drugs today intended to combat tomorrow’s resistant pathogens. Achaogen has established specialized capabilities to pursue the discovery and development of new antibiotics, and has funded its growth with a blend of private investments and non-dilutive funding from partnerships with the NIH, the United States Department of Defense, and others. For more information, please visit the company’s website at

News Articles [30 Associated News Articles listed on BioPortfolio]

Achaogen's plazomicin wins FDA breakthrough status

The FDA has granted breakthrough therapy designation to Achaogen's antibiotic plazomicin, intended to treat serious bacterial -More- 

Gates Foundation Supports Achaogen's Antibacterial Platform with $20.5M

The Bill and Melinda Gates Foundation has awarded Achaogen $10.5 million in grant funding and is making a $10 million investment in the South San Francisco-based firm to support the identification of ...

Achaogen nets $105.8mm via FOPO

Antibacterials developer Achaogen Inc. netted $105.8mm through the public sale of 5mm common shares at $22.50 per share. The company will use some of the proceeds for ongoing development of Phase III ...

Achaogen gains $10.5M grant from Gates foundation

South San Francisco, Calif.-based Achaogen has been awarded a $10.5 million grant from the Bill and Melinda Gates Foundation  -More- 

Achaogen Escalates

Achaogen raises $112.5M in follow-on

Achaogen, Syndax price follow-ons

Achaogen: Birth Of A Biotech Powerhouse

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Achaogen, Inc.

Achaogen is a clinical-stage biopharmaceutical company focused on the discovery and development of antibiotics for the treatment of serious infections caused by multi-drug resista...


Achaogen is a clinical stage biopharmaceutical company focused on the discovery and development of broad-spectrum antibiotics to treat multi-drug resistant bacterial infections.Â...

More Information about "Achaogen, Inc." on BioPortfolio

We have published hundreds of Achaogen, Inc. news stories on BioPortfolio along with dozens of Achaogen, Inc. Clinical Trials and PubMed Articles about Achaogen, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Achaogen, Inc. Companies in our database. You can also find out about relevant Achaogen, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record